Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07938476
NA

Effects of Bifidobacterium Longum Subsp. Infantis i18 on Gut Microbiota Development and Health in Early Life

Sponsor: DiproBio (Shanghai) Co., Ltd.

View on ClinicalTrials.gov

Summary

This study aims to evaluate the effects of Bifidobacterium longum subsp. infantis i18 supplementation on symptoms, gut microbiota development, and overall health outcomes in healthy infants and young children in China.

Official title: Effects of Bifidobacterium Longum Subsp. Infantis i18 Intervention on Early-Life Gut Microbiota Development and Health Outcomes: A Randomized, Double-Blind, Multicenter, Placebo-Controlled Clinical Study

Key Details

Gender

All

Age Range

0 Months - 36 Months

Study Type

INTERVENTIONAL

Enrollment

455

Start Date

2026-11-09

Completion Date

2028-12-31

Last Updated

2026-11-16

Healthy Volunteers

Yes

Interventions

DIETARY_SUPPLEMENT

Bifidobacterium longum subsp. infantis i18

Bifidobacterium longum subsp. infantis i18 supplementation.

DIETARY_SUPPLEMENT

Placebo

Matching placebo without the probiotic intervention

Locations (1)

First Hospital Hebei North University

Zhangjiakou, Hebei, China